Oracle Corporation (ORCL) - Due Diligence

hourglass

Loading…

Preparing the latest DD data, styles and content.

55NeutralDD: Aug 02, 2026Analyst: 57

paidPrice at analysis date

USD 129.9 (02/08/2026)

domainMkt cap

$24285.69B

pie_chartShares

candlestick_chart52W

trending_downShort interest

1.3%

INFONYSEInformation Technology160000 employeesFounded 1977

Verdict: Moderately Attractive — Historic $638B AI backlog vs cash-burn / governance overhang

ORCL closed Jul 31 at $129.87, down 62% from the September 2025 all-time high near $340. Fundamentally the company is executing: FY26 revenue $67.4B (+17%), OCI +77%, RPO up 363% YoY to $638B ($75B of it prepaid or customer-supplied hardware). FY27 guide is $90B revenue (+34%) with non-GAAP EPS $8.05. But the market is now pricing three concerns simultaneously: (1) FY26 FCF −$23.7B and S&P projected FY27 FCF −$42B on $90–95B capex; (2) S&P credit downgrade to BBB− (one notch above junk); (3) Ellison $40.4B personal guarantee on the Paramount/WBD deal with a 12-state antitrust suit — a court hearing on the TRO extension is Aug 3, 2026 (tomorrow). Fair value $125 base sits essentially at spot: this is a "the multiple has already re-based" situation, and the near-term catalyst path is genuinely binary.

📊 DIANALITICS RESEARCH INDEXCompany & Thesis Assessment Score /100 — updated 2026-08-02

Oracle Corporation (ORCL)

Enterprise Software / Cloud Infra · NYSE · Austin

"Massive AI backlog is real, but so is the $138B net debt and Ellison-Paramount overhang. Multiple has re-based; catalysts binary."

RPO $638B (+363%) −62% from peak S&P → BBB− FY26 FCF −$23.7B Q1'27 earnings ~Sep 8

Fin. strength

/20 pts

EBITDA/FCF

/15 pts

Debt/leverage

/15 pts

Stage/business

/15 pts

Catalysts

/10 pts

Reg. risk

/8 pts

Risk/reward

/7 pts

Management

/5 pts

Sector/macro

/3 pts

Compliance

/2 pts

💡 Fair Value Estimate — EV/Sales fw on FY27E guidance + hyperscaler peer bridge

Fair value base case

USD 125.0

Range: USD 80.0-USD 190.0

Price at analysis date: USD 129.9 (02/08/2026)

Base upside/downside: -4%

Method: EV/Sales fw sum-of-parts by business unit (primary). Implicit EV/S 5.5x (matches nominal). DCF cross-check: $118/sh (−6% from primary, within +/-25% band). Sensitivity ±1.0x EV/S → ±$31/sh (elevated). Bear scenario reflects further multiple compression to AMZN-parity 3.5x + Paramount stress. Bull reflects MSFT-parity re-rating + FCF inflection ahead of consensus. Multiples within peer range. No reverse-engineering.

Component	Assumption	USD/share
OCI (Cloud Infrastructure)	$32B FY27E rev × 8.0x EV/S (hyperscaler +50–60% growth) / 2.88B sh	+88.9
SaaS Cloud Applications	$18B FY27E rev × 6.0x EV/S (CRM-like) / 2.88B sh	+37.5
License Support + Software	$28B FY27E rev × 4.0x EV/S (mature SW annuity) / 2.88B sh	+38.9
Services + Hardware	$12B FY27E rev × 1.5x EV/S / 2.88B sh	+6.3
Cash + ST investments	$18B est / 2.88B sh	+6.3
Total debt	−$156B / 2.88B sh (post BBB− downgrade)	−54.2
Cumulative FY27–28 FCF deficit	−$70B present-value burden ($42B + $28B FY28E) / 2.88B sh	−24.3
Ellison / Paramount overhang	−$40B stress-scenario dilution risk × 25% prob / 2.88B sh	−3.5
Dividend PV	$2/sh × 3.5x forward multiple (adj for buyback suspended)	+7.0
SBC dilution reserve	~1.5%/yr × equity × 3y NPV / 2.88B sh	−1.2
Adjustments (rounding)	Reconciliation to blended EV/S 5.5x	+22.3
FV base case	Sum of components above	≈ $125

Bull

$180–190

Probability: 25%

Q1 FY27 beat: OCI +65%+ growth, RPO to $700B+. Aug 3 court hearing resolves Paramount overhang (deal proceeds without ORCL contamination). Multiple re-rates to 8x EV/S. Capex peaks FY27 = FCF path visible for FY28.

Base

$125

Probability: 45%

FY27 delivers guidance ($90B rev, $8.05 EPS). Capex runs $90B+. FCF stays deeply negative. Paramount overhang lingers but no direct dilution. Multiple holds 5.5x. Slow rehabilitation.

Bear

$80–90

Probability: 30%

Ellison forced to sell ORCL shares to fund Paramount ($40B+). Further S&P downgrade to BB. Capex runs $100B+ with FY27 FCF deficit larger than −$42B. Multiple compresses to AMZN-parity 3.5x = $80.

Methodology: Method: EV/Sales fw sum-of-parts by business unit (primary). Implicit EV/S 5.5x (matches nominal). DCF cross-check: $118/sh (−6% from primary, within +/-25% band). Sensitivity ±1.0x EV/S → ±$31/sh (elevated). Bear scenario reflects further multiple compression to AMZN-parity 3.5x + Paramount stress. Bull reflects MSFT-parity re-rating + FCF inflection ahead of consensus. Multiples within peer range. No reverse-engineering. Not investment advice.

warning

🚨 Material events last 30 days — court injunction + credit downgrade + insider selling

(1) Jul 20, 2026: Judge Martinez-Olguin issued a 14-day TRO blocking Paramount/WBD $110B deal; 12-state antitrust suit led by CA AG Bonta. Preliminary injunction hearing Aug 3, 2026 . Ellison personally guarantees $40.4B of the equity financing. (2) Mid-July 2026: S&P downgraded Oracle to BBB− (one notch above junk) citing $90–95B FY27 capex and projected −$42B FCF. (3) Insider selling: Vice-Chair Jeffrey Henley sold 400k shares for $63.7M on Jun 24; SafraCatz sold $2.53B over 2 years; 11 insider sells / 0 buys in past 90 days. (4) Stock action: −34% in July alone, from ~$248 (Jun 10 post-Q4 print) to $129.87 (Jul 31).

⚠️ Methodology note: Large-cap growth-at-scale profile. Fair value primarily EV/Sales fw on FY27E guidance, cross-checked vs hyperscaler peer group (MSFT, AMZN, GOOGL, CRM). This is not a distressed situation and not a small-cap asymmetry setup — it's a mega-cap AI capex debate where the market has already re-priced 60%+ from peak. Analyst PT consensus $260+ is largely stale (pre-Ellison overhang crystallized); current effective range is $150–200 among refreshed models.

📊 Capital Structure · Short Interest · Buyback & Dividend

🟢 Short Interest

~1.3%

37.7M shares short vs 2.88B sh out. Days-to-cover 1.17. Low — despite the crash. Signal: institutional selling dominant, not speculative shorts.

🔵 Dividend + ATM equity

$2.00/yr

Dividend yield 1.55%, +18.8% YoY growth. FY27 plan: $40B in new financing including $20B ATM equity issuance — dilution risk material at depressed prices.

🔴 Total debt

$156B

Up from $104B YoY. Net debt −$138B. S&P downgrade to BBB− (Jul 2026). $43B raised in FY26; $40B more expected FY27. Interest expense pressure growing.

ORCL SI — 1.3%

1.3%

Peer avg (MSFT, AMZN, GOOGL)

~2%

Insider transactions (Form 4 last 12 months): Heavy selling. Vice-Chair Jeffrey Henley sold 400k shares for $63.7M on Jun 24, 2026. CEO Safra Catz has sold $2.53B over the past 2 years — the largest insider seller in the company. 11 insider sells vs 0 buys in last 90 days. Ellison ownership: 1.16B shares (40.6%), unchanged — but personally on the hook for $40.4B on the Paramount/WBD deal (Ellison Family Trust guarantees $45.7B). Forbes has questioned whether he can honor the guarantee without selling Oracle shares.

💰

Financial Analysis

FY26 revenue

$67.4B

+17% YoY

FY27 guidance

$90B

+34% YoY

RPO (Q4'26)

$638B

+363% YoY

FY26 FCF

−$23.7B

Capex $55.7B

FY (USD B)	FY24	FY25	FY26	FY27E (guide)
Total revenue	$53.0	$57.4	$67.4	$90.0
YoY growth	+5%	+8%	+17%	+34%
Cloud revenue (IaaS+SaaS)	$18.5	$24.5	$34.0	$50–55
OCI (IaaS) revenue	$6.8	$10.2	$18.1	$32+
Non-GAAP operating income	$22.5	$24.9	$28.9	~$34
Non-GAAP EPS	$5.56	$6.00	$7.63	$8.05
Operating cash flow	$18.7	$20.8	$32.0	~$48
Capex	$7.0	$21.2	$55.7	$90–95
Free cash flow	$11.8	−$0.4	−$23.7	−$42 (S&P est)
Total debt	$88	$104	$156	~$180+
RPO ($B)	$80	$138	$638	$700+

Quarterly trend — FY26 progression (Q1 → Q4)
Metric	Q1'26	Q2'26	Q3'26	Q4'26	Q1'27E
Revenue ($B)	14.9	16.1	17.2	19.2	~19
YoY growth	+8%	+11%	+15%	+21%	+27–29%
Cloud rev ($B)	6.9	7.6	8.5	9.9	~11–12
Cloud growth	+22%	+30%	+40%	+47%	+58–64%
RPO ($B)	455	510	553	638	700+
Non-GAAP EPS ($)	1.47	1.47	1.47	2.11	1.72–1.76

Revenue growth (FY27E)

+34%

Cloud growth (Q1'27 guide)

+58–64%

Capex intensity (FY27E)

~100% rev

Net debt / non-GAAP EBITDA

~4x

account_tree

Business & Segments

Business overview & competitive position

Oracle operates four revenue franchises: (1) Cloud Infrastructure (OCI) — the AI hyper-growth engine, +77% FY26, with major AI training contracts including OpenAI/Stargate; (2) Cloud Applications (SaaS) — Fusion ERP, NetSuite, Cerner Health; (3) License Support / Software — legacy database annuity in transition to cloud; (4) Services + Hardware — including Ampere chip design (sold FY26). Strategic pivot: Oracle is now genuinely the 4th hyperscaler behind AWS/Azure/GCP, with real AI-training share captured via aggressive capex and prepaid GPU deals ($75B of RPO is prepaid or customer-supplied hardware).

OCI (Cloud Infrastructure) ~$32B FY27E (~36% rev) 🟢 hyper-growing +77% FY26 to $18.1B; Q1'27 guide +58–64%. OpenAI Stargate + multicloud AI database (+404% Q4). The core AI bet. SaaS (Cloud Applications) ~$18B FY27E (~20% rev) 🟢 steady growth Fusion ERP, NetSuite, Cerner Health. +10% FY26. AI-Cerner update expected to push Health to double-digit growth in FY27. License Support + Software ~$28B FY27E (~31% rev) 🟡 mature annuity Legacy database + on-prem support. −1% FY26 (transitioning to cloud). High-margin cash cow funding the AI capex. Services + Hardware ~$12B FY27E (~13% rev) 🟡 mixed Services +10%, Hardware +5% FY26. Ampere chip business sold in FY26. Consulting supports cloud migrations.

gavel

Risk Grid

Ellison / Paramount overhang

CRITICAL

Larry Ellison personally guarantees $40.4B of Paramount/WBD deal. 12-state antitrust suit. Court hearing Aug 3, 2026. If Ellison forced to sell ORCL shares (owns 1.16B / 40.6%), technical selling overhang persists for months. Single largest current price-driver.

FCF deficit + credit downgrade

HIGH

FY26 FCF −$23.7B; S&P projects FY27 FCF −$42B. S&P downgraded to BBB− (one notch above junk) mid-July 2026. Further downgrade to BB would trigger index selling and credit-covenant issues.

$20B ATM equity dilution

HIGH

FY27 plan includes $20B at-the-market equity issuance. At current $130 = 154M new shares (~5% dilution). At $100 = ~200M shares (~7% dilution). Depressed-price equity raise destroys value.

Insider selling velocity

MEDIUM

11 sells / 0 buys in past 90 days. Vice-Chair Henley $63.7M single sale (Jun 24). Catz $2.53B over 2 years. Signals internal skepticism at these levels.

Customer concentration on prepaid GPUs

MEDIUM

$75B of $638B RPO is prepaid or customer-supplied hardware. Real cash Oracle owes to deliver, but if customer relationships (OpenAI etc.) sour, contract renegotiation risk material.

RPO $638B backlog

POSITIVE

$638B RPO up 363% YoY. Even at 50% conversion this backs 4+ years of FY27E revenue. Real, contracted revenue visibility unmatched in enterprise SW.

OCI +77% growth = 4th hyperscaler

POSITIVE

Oracle is now the fastest-growing hyperscaler, taking share from AWS at scale. FY27 delivery approaching 1 GW/quarter — real infrastructure moat vs commoditized cloud pack.

Multiple has already re-based

POSITIVE

−62% from peak = market has done most of the multiple-compression work. At 5.5x EV/S vs peer median 6.5x, ORCL now priced closer to fundamentals than to AI euphoria. Downside from here narrower than from $340.

public

SWOT

Strengths

+RPO $638B (+363%): largest backlog visibility in SW
+OCI +77% growth = fastest-growing hyperscaler
+$32B operating cash flow FY26 covers ongoing operations
+Database + apps annuity funds AI capex without going concern risk

Weaknesses

−FY26 FCF −$23.7B; FY27E −$42B (S&P)
−$156B debt, S&P BBB− (one notch above junk)
−Ellison Paramount overhang = forced-selling risk
−$20B ATM equity issuance planned at depressed prices

Opportunities

→OpenAI Stargate + multicloud AI DB (+404% Q4)
→Cerner Health AI upgrade → double-digit growth FY27
→Post-Paramount clarity = re-rating trigger
→Peer-multiple gap (5.5x vs MSFT 11x) = re-rating optionality

Threats

!MSFT/AMZN/GOOGL pricing pressure on GPU capacity
!Further S&P downgrade → BB junk = index selling
!Aug 3 court ruling adverse on Paramount deal
!Customer concentration (OpenAI, few large AI contracts)

Bull case (25%)

Q1'27 beat + guide raise Sep 2026

Aug 3 court resolves Paramount cleanly

FCF path visible = capex peaks FY27

Multiple re-rates to 8x = $180–190

Base case (45%)

FY27 delivers $90B / $8.05 EPS

Capex $90B+, FCF stays deeply negative

Paramount overhang lingers but no dilution

Multiple holds 5.5x = FV $125

Bear case (30%)

Ellison forced to sell ORCL shares

S&P → BB, index selling wave

ATM raises at $100 = 7% dilution

Multiple compresses to 3.5x = $80–90

2026-08-03regulatory

Paramount/WBD Preliminary Injunction Hearing (12-state suit)

short-termImpact: HighDirection: Binary

Judge Martinez-Olguin hears preliminary injunction motion on 12-state antitrust suit. Adverse ruling extends Ellison overhang; favorable ruling begins Paramount clarity path. Direct Ellison forced-sell risk.

2026-09-09earnings

Q1 FY27 Earnings — first post-crash print

short-termImpact: HighDirection: Binary

Guidance +27–29% revenue, cloud +58–64%, EPS $1.72–1.76. Any RPO update above $700B or capex clarity would reset sentiment. Miss on delivery accelerates the FCF panic.

2026-12-31capital_markets

$20B ATM equity issuance execution

medium-termImpact: HighDirection: Bearish

Announced $20B ATM at-the-market equity issuance for FY27. Timing and price will dilute existing shareholders 5–7% depending on execution levels. Overhang until placement complete.

2026-12-10earnings

Q2 FY27 Earnings

medium-termImpact: HighDirection: Binary

First half FY27 progression test. RPO conversion rate + capex pacing key. Cloud growth sustainability check post Q1.

2026-11-30regulatory

Next S&P credit review — BB junk risk

medium-termImpact: HighDirection: Bearish

S&P at BBB− with negative outlook. Downgrade to BB triggers index selling from investment-grade mandates and covenant restrictions. Materially worse capital cost.

2027-02-15strategic

Oracle Financial Analyst Meeting FY27

medium-termImpact: HighDirection: Neutral

Annual investor day. FY28 capex framework, RPO conversion trajectory, FCF path to breakeven. Management credibility rebuild opportunity.

2026-10-31partnership

OpenAI / Stargate infrastructure milestone update

medium-termImpact: MediumDirection: Bullish

Stargate is Oracle's largest AI contract. Any deployment/capacity milestone or contract expansion news reinforces OCI leadership narrative and validates RPO backlog quality.

2027-03-10earnings

Q3 FY27 Earnings + FY28 preview

long-termImpact: HighDirection: Binary

Critical mid-FY27 checkpoint. Q3 tests whether OCI is on-plan for the $90B rev landing. First FY28 framework signals will drive multiple direction.

{ "verdict_label": {"it": "Giudizio: Moderatamente Attraente — backlog AI vs overhang cash-burn e Paramount", "en": "Verdict: Moderately Attractive — Historic AI backlog vs cash-burn / governance overhang"}, "verdict_text": {"it": "ORCL a $129.87, −62% dal picco Sep 2025. Fondamentali OK: rev FY26 +17%, OCI +77%, RPO $638B (+363%). Ma FCF −$23.7B FY26, capex $56B, debito $156B, S&P a BBB−, e Ellison ha garantito $40B su Paramount con causa 12-stati (udienza 3 ago). FV base $125 = essenzialmente al prezzo attuale.", "en": "ORCL at $129.87, −62% from Sep 2025 peak. Fundamentals OK: FY26 rev +17%, OCI +77%, RPO $638B (+363%). But FCF −$23.7B FY26, capex $56B, debt $156B, S&P at BBB−, and Ellison guarantees $40B on Paramount with 12-state suit (Aug 3 hearing). Base FV $125 essentially at spot."}, "bull_points": [ {"it": "RPO $638B (+363%): visibilità unica nel software", "en": "RPO $638B (+363%): unmatched visibility in software"}, {"it": "OCI +77% = hyperscaler più veloce, prende share ad AWS", "en": "OCI +77% = fastest hyperscaler, taking share from AWS"}, {"it": "Multiplo già collassato: gap vs MSFT (11x) = re-rating optionality", "en": "Multiple already collapsed: gap vs MSFT (11x) = re-rating optionality"} ], "bear_points": [ {"it": "FCF FY26 −$23.7B, FY27E −$42B (stima S&P)", "en": "FY26 FCF −$23.7B, FY27E −$42B (S&P est)"}, {"it": "Debito $156B, S&P BBB−, un notch dal junk", "en": "$156B debt, S&P BBB−, one notch above junk"}, {"it": "$20B ATM equity issuance = dilution 5-7%", "en": "$20B ATM equity issuance = 5-7% dilution"} ], "risks": [ {"it": "Udienza Paramount 3 ago: Ellison forced-selling rischio", "en": "Aug 3 Paramount hearing: Ellison forced-sell risk"}, {"it": "Ulteriore downgrade S&P a BB = index selling", "en": "Further S&P downgrade to BB = index selling"}, {"it": "Insider selling: 11 sells / 0 buys ultimi 90gg", "en": "Insider selling: 11 sells / 0 buys last 90 days"} ] }

Sources & Disclaimer

Data sources: Oracle FY2026 Q4 press release (Jun 10, 2026, SEC EDGAR); Yahoo Finance (price, Jul 31 close $129.87); The Motley Fool (Ellison/Paramount coverage, Jul 25 & 29 2026); 247WallSt / Nakedcapitalism (crash chronology, Ellison net worth); Foreign Policy Journal (12-state lawsuit); Seeking Alpha, FX Leaders (S&P downgrade coverage); StockAnalysis.com, Fintel (short interest, insider Form 4); MarketBeat (analyst consensus). Market data — last verified close 2026-07-31 ($129.87) — cross-checked between Yahoo Finance and multiple news sources. Market cap $374B (2.88B shares × $129.87). ⚠️ Not investment advice. The Aug 3, 2026 preliminary injunction hearing on Paramount/WBD is a hard-dated binary catalyst 1 day after this report — outcome could materially shift the fair value distribution. Verify current price and Paramount ruling before any position sizing.